Changes in Staphylococcus aureus density and lesion severity after topical application of povidone-iodine in cases of atopic dermatitis
- PMID: 9438904
- DOI: 10.1016/s0923-1811(97)00616-6
Changes in Staphylococcus aureus density and lesion severity after topical application of povidone-iodine in cases of atopic dermatitis
Abstract
A case-control study was performed to examine the efficacy of 10% povidone-iodine solution applied to atopic dermatitis patients. The density of Staphylococcus aureus on the eczematous lesions and the lesion severity before and after the topical application of povidone-iodine were compared. We found a 10-100-fold decrease in the density of S. aureus after povidone-iodine treatment in patients colonizing S. aureus at an initial density of > 1000 CFU/10 cm2. Erythema and exudation also decreased after povidone-iodine treatment in patients colonizing S. aureus at an initial density of > 1000 CFU/10 cm2. The 10% povidone-iodine solution disinfected S. aureus cells when added immediately after the cells were mixed in human plasma; however, 10% povidone-iodine solution only reduced the density of S. aureus cells by 10-100-fold when S. aureus cells were harvested after a 24 h incubation in human plasma. Staphylococcus aureus cells harvested after 24 h incubation in human plasma were often surrounded by fibrin bundles and cells circumscribed by fibrin bundles could not be disinfected with 10% povidone-iodine solution. We suggest that S. aureus cells may produce biofilm-like structures in atopic dermatitis patients and that these structures may help S. aureus cells resist the 10% povidone-iodine treatment.
Similar articles
-
New successful treatment with disinfectant for atopic dermatitis.Dermatology. 1997;195 Suppl 2:62-8. doi: 10.1159/000246033. Dermatology. 1997. PMID: 9403258
-
The importance of disinfection therapy using povidone-iodine solution in atopic dermatitis.Dermatology. 2002;204 Suppl 1:63-9. doi: 10.1159/000057728. Dermatology. 2002. PMID: 12011524
-
Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.Br J Dermatol. 2006 Oct;155(4):680-7. doi: 10.1111/j.1365-2133.2006.07410.x. Br J Dermatol. 2006. PMID: 16965415 Clinical Trial.
-
Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications.Br J Dermatol. 1998 Dec;139 Suppl 53:13-6. doi: 10.1046/j.1365-2133.1998.1390s3013.x. Br J Dermatol. 1998. PMID: 9990408 Review.
-
The role of antibacterial therapy in atopic eczema.Expert Opin Pharmacother. 2010 Apr;11(6):929-36. doi: 10.1517/14656561003659992. Expert Opin Pharmacother. 2010. PMID: 20307218 Review.
Cited by
-
Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort.Allergy. 2021 Jan;76(1):302-313. doi: 10.1111/all.14489. Epub 2020 Aug 9. Allergy. 2021. PMID: 32640045 Free PMC article.
-
Atopic dermatitis and fungi.Clin Microbiol Rev. 2002 Oct;15(4):545-63. doi: 10.1128/CMR.15.4.545-563.2002. Clin Microbiol Rev. 2002. PMID: 12364369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources